FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Cosette Pharmaceuticals' prochlorperazine edisylate as an original generic application for use as an antiemetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness
• Nausea
• Postoperative Nausea and Vomiting
• Schizophrenia
• Vertigo
• Vomiting

Drugs mentioned

• Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)